TABLE 2

Kinetic parameters for formation of α-OHT and N-DMT from TAM, 6β-hydroxytestosterone from testosterone, and 1-hydroxymidazolam from midazolam by CYP3A5-genotyped HLM

LiverCYP3A5 GenotypeN-DMTα-OHTMidazolam 1-HydroxylationTestosterone 6β-Hydroxylation
VmaxKmCLintFormation CLHVmaxKmCLintFormation CLH
pmol · min1 · mg protein1μMμl · min1 · mg1ml/minpmol · min1 · mg protein1μMμl · min1 · mg1ml/minnmol · min1 · mg1nmol · min1 · mg1
HH-860*1/*1359.114.3283.15237.247.314.551.655.553.2511.5
MCV-36*1/*1244.597.8631.1298.1617.6910.451.695.681.745.12
CD-8002*1/*1236.1910.6622.1671.241.7612.650.140.47NA1.27
CD-8052*1/*1279.3611.0825.2180.525.447.650.712.39NA1.6
HH-739*1/*1223.414.1553.83162.052.715.970.451.521.21.6
HH-785*1/*1253.763.3276.43220.104.26.00.72.364.15.8
Mean ± S.D.266.07 ± 49.316.9 ± 3.4548.65 ± 26.64144.88 ± 72.436.52 ± 5.827.88 ± 3.090.89 ± 0.643.00 ± 2.152.57 ± 1.344.48 ± 3.96
HH-1044*1/*3107.4119.425.5318.438.4925.820.331.110.8411.22
HH-525*1/*3135.96168.528.154.2322.910.180.610.51.18
HL-G*1/*3112.9221.525.2517.513.216.520.190.640.8ND
HL-W*1/*392.357.8611.7538.633.8916.760.230.78ND1.15
HH-776*1/*369.917.533.9913.355.2629.240.180.610.881.56
Mean ± S.D.103.71 ± 24.5516.47 ± 5.247 ± 3.1223.22 ± 10.185.02 ± 2.0822.25 ± 5.590.22 ± 0.060.75 ± 0.220.75 ± 0.171.28 ± 0.19
HH-189*3/*3112.423.8928.8791.492.070.712.919.762.8913.6
HH-507*3/*389.095.217.1355.67NDNDND0.4
XENO*3/*352.994.412.0439.56NDND0.540.13
HL-D*3/*397.3217.445.5818.601.89.620.190.640.250.59
HL-J*3/*3122.679.8412.4740.945.98.160.722.430.792.23
HL-P*3/*3106.097.6413.8945.464.397.960.551.850.95ND
HH-689*3/*373.999.37.9626.39NDND0.140.23
HL-R*3/*3153.6613.7211.236.877.0912.990.551.850.842.83
HL-Q*3/*364.997.348.8529.293.456.430.541.820.250.36
HH-639*3/*376.395.7613.2643.462.36.170.371.250.240.38
HH-1123*3/*378.1117.634.4314.803.6519.770.180.610.670.52
Mean93.439.2912.3340.233.838.980.752.530.752.13
S.D.28.964.956.6320.841.895.570.892.990.84.13
  • ND, not detected; NA, not available.